Presented By: Patrick E.
Dycoco
Objectives:
Definition of STIs: What are they?
Transmission: How are they spread?
Types of infection:
Bacterial (Chlamydia, LGV, Gonorrhea, Syphilis)
Viral (HSV, HIV, HPV)
Parasitic (trichomoniasis)
STI vs STD
STI Infections acquired through sexual
intercourse (may be symptomatic or
asymptomatic)
STD Symptomatic disease acquired
through sexual intercourse
STI is most commonly used because it
applies to both symptomatic and
asymptomatic infections
Sexually Transmitted Infections
Infections that are most commonly
passed through sexual contact:
Oral
Vaginal
Anal
Skin-to-skin
Syphilis
Treponema Pallidum
Incubation period: 3-90 days
Syphilis: Clinical
6
Primary Phase
Presentation
Primary chancre
Begins as papule and erodes into
painless ulcer with a hard edge
and clean base
Usually in the genital area
Appears 9-90 days after
exposure
Can be solitary or multiple (eg.
kissing lesions)
Heals with scarring in 3-6 weeks
and 75% of patients show no
further symptoms
Syphilis: Clinical Presentation
(continued)
Primary / Infectious / Early Syphilis Stage:
Secondary Phase
Occurs 4 to 10 weeks after chancre
Lasts several weeks
Accompanied with fever, malaise, generalized
lymphadenopathy, and patchy alopecia
Maculo-papular rash usually on palms and soles
Condyloma lata on perianal or vulval areas
Possible mild hepatosplenomegaly
7
Syphilitic Rash
Credit: Dr. Gavin Hart and CDC
Credit: Connie Celum and Walter Stamn
and Seattle STD/HIV Prevention Training Center
Condyloma lata
Condyloma
lata
Credit: CDC
Syphilis: Clinical Presentation (continued)
Secondary / Latent Stage:
Positive serology
Rapid Plasma Reagin (RPR)
Venereal Disease Research Lab (VDRL)
Patients are asymptomatic and not
infectious after first year, but may relapse
One-third will convert to sero-negative status
One-third will stay sero-positive but
asymptomatic
One-third will develop tertiary syphilis
10
11
Syphilis: Clinical
Presentation (continued)
Tertiary Stage:
Cardiovascular: Aortic valve
disease, aneurysms
Neurological: Meningitis,
encephalitis, tabes dorsalis,
dementia
Gumma formation: Deep
cutaneous granulomatous
pockets
Orthopedic: Charcots joints,
osteomyelitis
Renal: Membranous
Glomerulonephritis
Maternal Syphilis
May cause:
Fetal death
Fetal growth restriction
Neonatal infection
Syphilis: Diagnosis
Non-Specific Treponemal Tests:
1. Venereal Disease Research
Laboratory
(VDRL)
2. Rapid Plasma Reagin (RPR)
13
Syphilis: Diagnosis (continued)
Positive serology on blood or CSF
Specific Treponemal Test:
1. Fluorescent Treponemal Antibody Absorption
(FTA-ABS)
2. Microhemagglutination-Treponema pallidum
(MHA-TP)
Organism may not be cultured but diagnosis
cannot be determined by clinical findings only
15
Syphilis: Treatment Considerations
16
Gonorrhe
a
17
N. gonorrhoeae-gram negative
diplococci
18
Credit: Negusse Ocbamichael and Seattle STD/HIV Prevention Training Center
Risk factors
Age <25
Prior gonococcal infection
Multiple sexual partners
Drug use
Gonorrhea: Clinical Presentation
Signs and Symptoms
Frequently asymptomatic
Areas of Infection
Urethra
Endocervix
Vaginal discharge
Abnormal uterine
bleeding
Dysuria
Upper genital
tract
Pharynx
Rectum
Mucopurulent cervicitis
Lower abdominal pain
20
Effects on pregnancy
Pre term delivery
Premature rupture of membranes
Chorioamnionitis
Postpartum infection
Gonorrhea: Diagnosis
Clinical exam
Cervical culture
Polymerase chain reaction (PCR) or ligase chain
reaction (LCR)
Gram stainpolymorphonucleocytes with gram
negative intracellular diplococci
22
Gonorrhea: Treatment Considerations
Intramuscular Ceftriaxone 125 mg
For pregnant women only:
Ceftriaxone single dose but substitute Quinolones with
Erythromycin
Evaluate and treat all sexual partners
23
Chlamydia
Chlamydia trachomatis
24
Risk factors
<25 years old
Multiple sexual partners
New sexual partner within 3 months
Presence or history of other STD(s)
Chlamydia: Clinical Presentation
Mucopurulent cervicitis/vaginal discharge
Dysuria
Lower abdominal pain
Urethritis, salpingitis, and proctitis
Post coital bleeding friable cervix
Key Considerations:
50% of females are asymptomatic
Sterile pyuria with urinary tract symptoms should
trigger you to think chlamydia
26
Effects on Pregnancy
Preterm Labor
PROM
Amnionitis
Fever
SGA
Neonatal septicemia
Fetal effects
Inclusion conjunctivitis
Neonatal pneumonia
Cervicitis
29
Credit: University of Washington and
Seattle STD/HIV Prevention Training Center
Chlamydia: Diagnosis
Chlamydia culture
New tests include:
Direct immunofluorescence assays (DFA)
Enzyme immunoassay (EIA)
Nucleic Acid Amplification Testing (NAAT)
30
Lymphogranuloma Venereum
Caused by Chlamydia trachomatis.
Develops inguinal adenitis and leads to
suppuration
Treatment
Erythromycin 500mg orally 4x daily for
21 days.
Herpes Simplex Virus
(HSV)
33
HSV: Clinical Presentation
Primary Infection
Prodrome phase:
Tingling/itching of skin
Appearance of painful
vesicles in clusters on an
erythematous base
Vesicles ulcerate then crust
over and heal within 7-14
days
Viral shedding continues for
up to 2-3 weeks
Recurrent Disease
After primary infection,
virus migrates to sacral
ganglion and lies
dormant
Reactivation occurs due
to various triggers
Reoccurrence is usually
milder and shorter in
duration
34
Herpes Simplex in Women with AIDS
36
Credit: Jean R. Anderson, MD
Neonatal routes
Intrauterine(5%)
Peripartum (85%)
Postnatal (10%)
HSV: Diagnosis
Clinical presentation
Viral culture
Tzanck smear/Giemsa smear
Skin biopsy
38
Human Papillomavirus
One of the most common sexually transmitted
infections.
Oncogenic HPV types 16 and 18 are associated with
dysplasia
External Genital Warts Condyloma Acuminata
-increase in number and size during pregnancy
Treatment: Trichloroacetic or bichloracetic, 80-90%
solution applied topically once a week.
Bacterial Vaginosis
Maldistribution of normal vaginal flora
Decreased lactobacilli and overrepresented species
are anaerobic bacteria that include Gardnerella
Vaginalis, Mobiluncus, and some Bacteroides species.
Treatment: Metronidazole 500mg twice daily for 7
days.
Trichomoniasis
Trichomonas vaginalis
43
Trichomoniasis: Clinical Presentation
Signs and symptoms:
Vulvar irritation
Dysuria
Dyspareunia
Pale yellow, malodorous - gray/green
frothy discharge
Strawberry cervix, inflamed and friable
44
Strawberry Cervix
45
Credit: Claire E. Stevens and Seattle STD/HIV Prevention Training Center
Trichomoniasis: Diagnosis
Flagellated, motile trichomonads on wet
mount
Vaginal pH > 4.5
Diagnosis confirmed by microscopy
46
Trichomoniasis: Treatment Considerations
For HIV-infected women: same treatment
as non-HIV infected women
Metronidazole or Tinidazole
Sex partners have to be treated
47
HIV
49
What Is HIV/AIDS?
Acquired immunodeficiency syndrome (AIDS)
is caused by the human immunodeficiency
virus (HIV).
HIV attacks and destroys white blood cells,
causing a defect in the bodys immune
system.
Etiopathogenesis
Causative agents of AIDS are RNA
retroviruses
Most cases worldwide are caused by
HIV-1 infection.
Clinical manifestations
Incubation: 3-6 weeks
Common symptoms
Fever, rash, headache, lymphadenopathy,
pharyngitis, myalgias, arthralgias, nausea,
vomiting and diarrhea.
HIV Transmission from Mother to Infant
52
Antenatal
In utero by transplacental passage
Intranatal
Exposure to maternal blood and vaginal
secretions during labor and delivery
Postnatal
Postpartum through breastfeeding
HIV and Pregnancy
Pregnancy does not
accelerate the
progression of HIV
disease to AIDS
Patients with AIDS
are more likely to
suffer from
pregnancy-related
complications
53
Effect of Advanced HIV on
Pregnancy
Decreased fertility
Spontaneous abortion
Infections (opportunistic, GU, postpartum,
post-surgical)
Preterm labor
Premature rupture of membranes
Low birth weight babies
Stillbirths
54
Factors Influencing MTCT
Viral Load
The higher the viral load, the higher the risk of
MTCT
Lower risk through:
Use of ART during pregnancy and postpartum to
mother and newborn
Adequate nutrition, particularly vitamin A
55
Factors Influencing MTCT (2)
Maternal factors increasing risk:
Viral or parasitic placental infection
(especially malaria)
Becoming infected with HIV during
pregnancy
Severe immune deficiency
Advanced clinical and immunological state
Maternal malnutrition
56
Factors Influencing MTCT (3)
Labor and delivery factors increasing risk:
Prolonged rupture of membranes (>4 hours)
Injury to birth canal during child birth
Antepartum procedures
Acute chorioamnionitis
Invasive fetal monitoring
Instrumental delivery
Mixing of maternal and fetal body fluids
Delayed infant cleaning and eye care
Routine infant airway suctioning
57
Factors Influencing MTCT (4)
Fetal Conditions increasing risk:
Premature delivery
Low birth weight
Immature immune status
First infant in a multiple birth
Oral diseases
58
Antenatal Care
Primary prevention during pregnancy
Education about safer sex with use of
condoms for mother and father
Early treatment of STIs
Safer sex during pregnancy and
lactation
59
Initial Examination
All pregnant women
Syphilis test
Hgb
HIV counseling and consent
HIV test (rapid, if available)
Rule out active TB
If HIV positive:
Baseline TLC
CD4 and CD8 counts
CD4/CD8 ratio and all other baseline tests (CBC, LFT, etc.)
Viral load screening
60
Labor and Delivery Care
Labor and Delivery Care
Offer HIV testing for women in labor
If a woman accepts an HIV test, provide
counseling and rapid test
62
Cesarean Section (CS)
Reduces the risk of MTCT
Not available and safe in many settings
Not routinely performed for women with HIV
infection in developing countries
Risks of morbidity associated with CS needs to
be carefully balanced with risk of MTCT
64
Postnatal Care of Mother
Routine postnatal care
Infant follow-up
Close monitoring for secondary postpartum hemorrhage
Early recognition and treatment of infections
Continue on HAART if patient is eligible (if on HAART while
pregnant)
Commence on HAART if patient is eligible (if HAART was not
started while pregnant)
65
Postnatal Care of Mother (2)
Extra nutrition and micronutrient support
Counseling about safe disposal of infectious
soiled pads or other garments
Family planning counseling
Infant feeding counseling
Social support
66
Family Planning
Discuss family planning BEFORE discharge
Assess risk behaviors and counsel on suitable
and effective methods
Review birth control and infection control
Dual protection to prevent and reduce further HIV
infection, STIs and pregnancy
Access to emergency contraception
68
END
Thank you